Literature DB >> 19136613

Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice.

Kostja Renko1, Peter J Hofmann, Mette Stoedter, Birgit Hollenbach, Thomas Behrends, Josef Köhrle, Ulrich Schweizer, Lutz Schomburg.   

Abstract

The acute-phase response (APR) is characterized by an impaired metabolism of the essential trace element selenium (Se). Moreover, low-Se concentrations correlate to mortality risk in sepsis. Therefore, we analyzed the expression of the central Se transport and storage protein selenoprotein P (Sepp1) during an APR in mice. Serum Se and Sepp1 concentrations declined in parallel after injection of lipopolysaccharide to 50 and 39% of control-injected littermates, respectively. This negative APR proceeded largely independent from hepatic Sepp1 transcript concentrations. Instead, we identified a set of hepatic transcripts involved in Se metabolism, which declined coordinately during the APR, including the selenocysteine-specific elongation factor (EFsec), selenophosphate-synthetase 2 (Sephs2), selenocysteine-tRNA[Ser]Sec synthase (SecS), and phosphoseryl-tRNA[Ser]Sec kinase (Pstk). Pstk reacted most strongly and qualified as a new limiting factor for Sepp1 biosynthesis in siRNA-mediated knockdown experiments in hepatocytes in culture. Analogous experiments were performed with mice transgenic for hepatocyte-specific human Sepp1 cDNA to verify this hypothesis. Similar kinetics and effect sizes of Sepp1 expression were observed as before in wild-type mice. We conclude that hepatic translation of Sepp1 mRNA is specifically impaired during the APR. This deficit disrupts regular Se metabolism, transport, and supply to peripheral tissues and likely aggravates the pathological status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136613     DOI: 10.1096/fj.08-119370

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  34 in total

Review 1.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

Review 2.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

3.  Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.

Authors:  Kazuhide Ishikura; Hirofumi Misu; Masafumi Kumazaki; Hiroaki Takayama; Naoto Matsuzawa-Nagata; Natsumi Tajima; Keita Chikamoto; Fei Lan; Hitoshi Ando; Tsuguhito Ota; Masaru Sakurai; Yumie Takeshita; Kenichiro Kato; Akio Fujimura; Ken-Ichi Miyamoto; Yoshiro Saito; Satomi Kameo; Yasuo Okamoto; Yoh Takuwa; Kazuhiko Takahashi; Hiroyasu Kidoya; Nobuyuki Takakura; Shuichi Kaneko; Toshinari Takamura
Journal:  Diabetologia       Date:  2014-07-03       Impact factor: 10.122

4.  Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes.

Authors:  Xiaodan Liu; Kathryn E Pietsch; Shana J Sturla
Journal:  Chem Res Toxicol       Date:  2011-04-12       Impact factor: 3.739

5.  Selenoprotein P regulation by the glucocorticoid receptor.

Authors:  Colleen Rock; Philip J Moos
Journal:  Biometals       Date:  2009-12       Impact factor: 2.949

6.  Thyroid hormones regulate selenoprotein expression and selenium status in mice.

Authors:  Jens Mittag; Thomas Behrends; Carolin S Hoefig; Björn Vennström; Lutz Schomburg
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

7.  Metabolomics signature associated with circulating serum selenoprotein P levels.

Authors:  Romina di Giuseppe; Manja Koch; Ute Nöthlings; Gabi Kastenmüller; Anna Artati; Jerzy Adamski; Gunnar Jacobs; Wolfgang Lieb
Journal:  Endocrine       Date:  2018-11-17       Impact factor: 3.633

8.  Lack of Association between Selenium Status and Disease Severity and Activity in Patients with Graves' Ophthalmopathy.

Authors:  Nora Dehina; Peter Josef Hofmann; Thomas Behrends; Anja Eckstein; Lutz Schomburg
Journal:  Eur Thyroid J       Date:  2016-01-16

Review 9.  The human selenoproteome: recent insights into functions and regulation.

Authors:  M A Reeves; P R Hoffmann
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

Review 10.  Selenoprotein P-expression, functions, and roles in mammals.

Authors:  Raymond F Burk; Kristina E Hill
Journal:  Biochim Biophys Acta       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.